Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Line M Myklebust

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Human Genetics : EJHG|August 8, 2014
De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and femalesBernt Popp, Svein I Støve, Sabine Endele, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2018
Structural determinants and cellular environment define processed actin as the sole substrate of the N-terminal acetyltransferase NAA80Marianne Goris, Robert S Magin, Håvard Foyn, et al.
Nature Communications|July 18, 2015
Downregulation of N-terminal acetylation triggers ABA-mediated drought responses in ArabidopsisEric Linster, Iwona Stephan, Willy V Bienvenut, et al.
Journal of Inherited Metabolic Disease|September 3, 2020
Functional evaluation of 16 SCHAD missense variants: Only amino acid substitutions causing congenital hyperinsulinism of infancy lead to loss-of-function phenotypes in vitroKelly Velasco, Johanna L St-Louis, Henrikke N Hovland, et al.
Human Molecular Genetics|December 10, 2014
Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defectsLine M Myklebust, Petra Van Damme, Svein I Støve, et al.
European Journal of Human Genetics : EJHG|May 12, 2018
A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathySvein Isungset Støve, Marina Blenski, Asbjørg Stray-Pedersen, et al.
Cancer Cell|February 15, 2011
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in CaucasiansStian Knappskog, Merete Bjørnslett, Line M Myklebust, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Human Genetics : EJHG|August 8, 2014
De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and femalesBernt Popp, Svein I Støve, Sabine Endele, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2018
Structural determinants and cellular environment define processed actin as the sole substrate of the N-terminal acetyltransferase NAA80Marianne Goris, Robert S Magin, Håvard Foyn, et al.
Nature Communications|July 18, 2015
Downregulation of N-terminal acetylation triggers ABA-mediated drought responses in ArabidopsisEric Linster, Iwona Stephan, Willy V Bienvenut, et al.
Journal of Inherited Metabolic Disease|September 3, 2020
Functional evaluation of 16 SCHAD missense variants: Only amino acid substitutions causing congenital hyperinsulinism of infancy lead to loss-of-function phenotypes in vitroKelly Velasco, Johanna L St-Louis, Henrikke N Hovland, et al.
Human Molecular Genetics|December 10, 2014
Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defectsLine M Myklebust, Petra Van Damme, Svein I Støve, et al.
European Journal of Human Genetics : EJHG|May 12, 2018
A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathySvein Isungset Støve, Marina Blenski, Asbjørg Stray-Pedersen, et al.
Cancer Cell|February 15, 2011
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in CaucasiansStian Knappskog, Merete Bjørnslett, Line M Myklebust, et al.
Pageof 2